Jonathan Douxfils to Humans
This is a "connection" page, showing publications Jonathan Douxfils has written about Humans.
Connection Strength
0.189
-
Antibody titres decline 3-month post-vaccination with BNT162b2. Emerg Microbes Infect. 2021 Dec; 10(1):1495-1498.
Score: 0.008
-
Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ. J Infect. 2021 10; 83(4):e4-e5.
Score: 0.008
-
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. Viruses. 2021 07 14; 13(7).
Score: 0.008
-
Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccination. J Infect. 2022 01; 84(1):94-118.
Score: 0.008
-
Evaluations of SARS-CoV-2 Serological Assay Performance Need Inclusion of Long-Term Samples. J Clin Microbiol. 2021 05 19; 59(6).
Score: 0.008
-
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thromb Res. 2021 07; 203:163-171.
Score: 0.008
-
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2). Clin Microbiol Infect. 2021 Sep; 27(9):1351.e5-1351.e7.
Score: 0.008
-
Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients. Clin Chem Lab Med. 2021 04 27; 59(5):e179-e183.
Score: 0.007
-
Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins. J Med Virol. 2021 04; 93(4):2262-2269.
Score: 0.007
-
Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study. Clin Chem Lab Med. 2020 09 25; 58(10):e193-e196.
Score: 0.007
-
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies. Clin Chem. 2020 08 01; 66(8):1104-1106.
Score: 0.007
-
Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia. Br J Haematol. 2020 08; 190(4):e187-e189.
Score: 0.007
-
The role of serology for COVID-19 control: Population, kinetics and test performance do matter. J Infect. 2020 08; 81(2):e91-e92.
Score: 0.007
-
Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application. J Thromb Haemost. 2019 08; 17(8):1273-1287.
Score: 0.007
-
An update on laboratory assessment for direct oral anticoagulants (DOACs). Int J Lab Hematol. 2019 May; 41 Suppl 1:33-39.
Score: 0.007
-
Optimal wavelength for the clot waveform analysis: Determination of the best resolution with minimal interference of the reagents. Int J Lab Hematol. 2019 Jun; 41(3):316-324.
Score: 0.006
-
Development of new methodologies for the chromogenic estimation of betrixaban concentrations in plasma. Int J Lab Hematol. 2019 Apr; 41(2):250-261.
Score: 0.006
-
Betrixaban: Impact on Routine and Specific Coagulation Assays-A Practical Laboratory Guide. Thromb Haemost. 2018 Jul; 118(7):1203-1214.
Score: 0.006
-
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J Thromb Haemost. 2018 02; 16(2):209-219.
Score: 0.006
-
An optimized dRVVT-based assay to estimate the intensity of anticoagulation in patients treated with direct oral anticoagulants. Thromb Res. 2017 Sep; 157:29-37.
Score: 0.006
-
Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels. Thromb Res. 2017 08; 156:36-38.
Score: 0.006
-
Laboratory Assessment of Direct Oral Anticoagulants. Semin Thromb Hemost. 2017 Apr; 43(3):277-290.
Score: 0.006
-
Measuring Direct Oral Anticoagulants. Methods Mol Biol. 2017; 1646:217-225.
Score: 0.006
-
Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients. J Med Virol. 2021 May; 93(5):3277-3281.
Score: 0.002
-
An original multiplex method to assess five different SARS-CoV-2 antibodies. Clin Chem Lab Med. 2021 04 27; 59(5):971-978.
Score: 0.002
-
Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance, and their limitations. J Thromb Haemost. 2020 11; 18(11):3121-3124.
Score: 0.002
-
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study. Thromb Res. 2021 01; 197:20-23.
Score: 0.002
-
[Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?] Ann Biol Clin (Paris). 2020 10 01; 78(5):471-481.
Score: 0.002
-
High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies. Clin Biochem. 2020 Dec; 86:23-27.
Score: 0.002
-
Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody. Clin Chem Lab Med. 2020 Jul 28; 58(8):1357-1364.
Score: 0.002
-
Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. J Med Virol. 2021 02; 93(2):803-811.
Score: 0.002
-
Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass. J Am Coll Cardiol. 2019 10 29; 74(17):2178-2189.
Score: 0.002
-
Prospective and comparative study of paroxysmal nocturnal hemoglobinuria patients treated or not by eculizumab: Focus on platelet extracellular vesicles. Medicine (Baltimore). 2019 Jul; 98(27):e16164.
Score: 0.002
-
Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE. Thromb Haemost. 2019 Apr; 119(4):675-684.
Score: 0.002
-
The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generation. Thromb Res. 2018 11; 171:160-166.
Score: 0.002
-
Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method. Int J Lab Hematol. 2018 12; 40(6):e105-e108.
Score: 0.002
-
The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs. Thromb Res. 2018 08; 168:63-66.
Score: 0.002
-
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants. Thromb Haemost. 2018 03; 118(3):437-450.
Score: 0.002
-
Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures. Expert Opin Biol Ther. 2017 10; 17(10):1275-1296.
Score: 0.001
-
Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme. Int J Lab Hematol. 2017 Aug; 39(4):402-408.
Score: 0.001
-
Application of a clot-based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates. Blood Transfus. 2018 02; 16(2):163-172.
Score: 0.001
-
Inactivation of human coagulation factor X by a protease of the pathogen Capnocytophaga canimorsus. J Thromb Haemost. 2017 03; 15(3):487-499.
Score: 0.001